Written by The American Journal of Medicine Published on January 26, 2021
The American Journal of Medicine now (Jan. 2021) now recommendsHydroxychloroquine,Azithromycin,andZinc for the treatment of Covid 19 outpatients.
The irony is this is the treatment that former US President, Donald Trump promoted last year. The timing, right after the election, is interesting.
Select extracts are below:
Approximately 9 months of the severe acute respiratory syndrome coronavius-2 (SARS-CoV-2 [COVID-19]) spreading across the globe has led to widespread COVID-19 acute hospitalizations and death.
This article outlines key pathophysiological principles that relate to the patient with early infection treated at home. Therapeutic approaches based on these principles include 1) reduction of reinoculation, 2) combination antiviral therapy, 3) immunomodulation, 4) antiplatelet/antithrombotic therapy, and 5) administration of oxygen, monitoring, and telemedicine. Future randomized trials testing the principles and agents discussed will undoubtedly refine and clarify their individual roles…
View original post 758 more words
One thought on “The American Journal Of Medicine Now Recommends HCQ For COVID19”